Chapel Hill, NC – The cost of sequencing the entire human genome, or exome – the regions of the genome that are translated into proteins that affect cell behavior – has decreased significantly, to the point where the cost of looking at the majority of a patient’s genomic data may be less expensive than undertaking one or two targeted genetic tests.
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in recent articles in The News & Observer and the Scientific American blog.
Training the next generation of scientists is vital to continued progress in understanding cancer and all human disease. But how do students evaluate the programs offered by colleges and universities to decide which program is the best fit for them?
Findings guide future research on chemotherapy resistance